PHARMARON BEIJING H YC1 financial statements, including revenue, expenses, profit, and loss
The total revenue of 17Q1 for the last quarter is 400.57 M EUR, and it's 5.82% higher compared to the previous quarter. The net income of Q3 24 is 38.76 M EUR.